A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.
about
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A phase 2 randomized trial to ...... design of the CARDAPAC study.
@ast
A phase 2 randomized trial to ...... design of the CARDAPAC study.
@en
type
label
A phase 2 randomized trial to ...... design of the CARDAPAC study.
@ast
A phase 2 randomized trial to ...... design of the CARDAPAC study.
@en
prefLabel
A phase 2 randomized trial to ...... design of the CARDAPAC study.
@ast
A phase 2 randomized trial to ...... design of the CARDAPAC study.
@en
P2093
P2860
P1433
P1476
A phase 2 randomized trial to ...... : design of the CARDAPAC study
@en
P2093
Bruno Degano
Dewi Vernerey
Fabienne Mougin
Franck Bonnetain
Gilles Dumoulin
Malika Bouhaddi
Marion Chatot
Nathalie Meneveau
P2860
P2888
P356
10.1186/S12885-017-3420-4
P407
P577
2017-06-19T00:00:00Z
P6179
1086108377